JGQ-30970-39005
3 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 760 / TX
- Registered
- 2020-12-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-25
Registered in v-safe
- 2020-12-25
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-19
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-04-14
-
2021-08-21
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-11-22
-
2022-02-21
Survey response — 6 months, dose 3MedDRA: Chills, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever, chillsMedDRA releases: 2024-11 · check-in free text available
- 2022-08-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-08-21 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Fever, chills
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release